MLH1 and colorectal cancer: In patients with colorectal cancer, Castillejo et al. [17] found MLH1 constitutional epimutation in five of 847 patients who met the revised Bethesda guidelines (0.59%), but in zero of 2123 patients who did not meet the guidelines.